361 Capital’s Johnson & Johnson JNJ Stock Holding History

361 Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,876	Closed	-$2.08M	–	304
2017 Q4	$2.08M	Buy	+14,876	New	+$2.07M	0.51%	95

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

361 Capital's JNJ Position: Q1 2018 in Review

361 Capital sold out of Johnson & Johnson (JNJ) in Q1 2018, closing a stake of 14,876 shares — an estimated $2.08M sold.

361 Capital first reported a position in JNJ in Q4 2017 and held it in 1 quarter. The position peaked at $2.08M in Q4 2017. 2,598 funds tracked by Wall St. Rank hold JNJ as of Q1 2018.

361 Capital reported no remaining Johnson & Johnson position as of Q1 2018 after selling out during the quarter.
361 Capital sold 14,876 Johnson & Johnson shares in Q1 2018, an estimated $2.08M.
361 Capital first reported a position in Johnson & Johnson in Q4 2017 and held it in 1 quarter.
361 Capital's Johnson & Johnson position peaked at $2.08M in Q4 2017.
2,598 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2018.

Based on 361 Capital's 13F filing for Q1 2018, filed 15 May 2018.